# STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

> **NCT06574880** · PHASE1,PHASE2 · RECRUITING · sponsor: **Angela Y. Jia, MD PhD** · enrollment: 45 (estimated)

## Conditions studied

- Malignant Neoplasm of Prostate
- Locally Advanced Prostate Cancer

## Interventions

- **DRUG:** Lu-PSMA-617
- **RADIATION:** 5-fraction Stereotactic Body Radiation Therapy (SBRT)

## Key facts

- **NCT ID:** NCT06574880
- **Lead sponsor:** Angela Y. Jia, MD PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-13
- **Primary completion:** 2026-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06574880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06574880, "STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06574880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*